D3017
D3017 is the main metabolite of D2624, which has oral bioactivity and anti-convulsant effects. D3017 ED50 value is 1.5 mg/kg in mice, and it can be used for research on severe generalized tonic-clonic seizures (grand mal) and complex partial epilepsy[1].
Product Specifications
CAS Number
[130403-18-8]
UNSPSC
12352005
Target
Endogenous Metabolite
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Smiles
O=C(C1=NOC(CO)=C1)NC2=C(C)C=CC=C2C
Molecular Formula
C13H14N2O3
Molecular Weight
246.26
References & Citations
[1]F Lepage, et al. New N-aryl isoxazolecarboxamides and N-isoxazolylbenzamides as anticonvulsant agents. Eur JMed Chem (1992) 27,581-593.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal C1QB Antibody (C1QB/2961) [HRP]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
![Rabbit Polyclonal CCDC6 Antibody [Janelia Fluor 549]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
